Sale!

H. Influenza RNA Detection Qualitative Test

1,160 د.إ

-15%

The H. Influenza RNA Detection Qualitative Test is a diagnostic procedure designed to identify the presence of Haemophilus influenzae RNA in a patient’s sample, typically a throat swab or sputum. This test employs molecular techniques, such as polymerase chain reaction (PCR), to qualitatively detect the genetic material of the H. influenzae bacteria, which is responsible for a range of infections from mild ear infections to serious conditions like meningitis.

The qualitative nature of the test means it is used to determine the presence or absence of the bacteria, rather than quantifying the amount present in the sample. It is particularly useful in clinical settings for early detection and appropriate management of infections caused by H. influenzae.

The test is available at DNA Labs UAE, a leading facility in the region for advanced diagnostic services. The cost of the H. Influenza RNA Detection Qualitative Test at DNA Labs UAE is 1160 AED. This price reflects the sophisticated technology and expertise required to perform the test and provide reliable results. Patients seeking this test can expect state-of-the-art services in a facility that adheres to high standards of diagnostic accuracy and patient care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

H. Influenza RNA Detection Qualitative Test

Welcome to DNA Labs UAE, a leading genetic lab offering a wide range of diagnostic tests. In this blog post, we will be discussing the H. Influenza RNA Detection Qualitative Test, including its cost, symptoms, diagnosis, and more.

Test Details

The H. Influenza (RNA Detection) Qualitative Test is a diagnostic test used to detect the presence of RNA from the Haemophilus influenzae bacterium. This test is primarily used in clinical laboratories to identify the presence of H. Influenzae in patient samples, such as blood, cerebrospinal fluid, or respiratory secretions.

H. Influenzae is a gram-negative bacterium that can cause a variety of infections, including respiratory tract infections, meningitis, and bacteremia. Rapid and accurate detection of H. Influenzae is crucial for appropriate patient management and treatment decisions.

The qualitative test involves the use of a nucleic acid amplification technique, such as polymerase chain reaction (PCR) or loop-mediated isothermal amplification (LAMP), to amplify the RNA from H. Influenzae in the patient sample. The amplified RNA is then detected using specific molecular probes that bind to the target RNA sequence of H. Influenzae.

The test results are usually reported as either positive or negative for the presence of H. Influenzae RNA. A positive result indicates that the bacterium is present in the patient sample, while a negative result suggests its absence.

The H. Influenza (RNA Detection) Qualitative Test offers several advantages, including high sensitivity and specificity, rapid turnaround time, and the ability to detect low levels of H. Influenzae in the sample. It is a valuable tool for the diagnosis of H. Influenzae infections and helps guide appropriate treatment decisions.

It is important to note that this test specifically detects RNA from H. Influenzae and cannot differentiate between different strains or serotypes of the bacterium. Additional testing may be required to determine the specific strain or serotype present in the patient sample.

Cost and Symptoms

The cost of the H. Influenza RNA Detection Qualitative Test is AED 1160.0. The test is commonly used for patients with symptoms such as respiratory tract infections, meningitis, and bacteremia. If you are experiencing any of these symptoms, it is recommended to consult a physician for further evaluation.

Diagnosis and Test Type

The H. Influenza RNA Detection Qualitative Test is conducted using the Real Time PCR method. This test falls under the category of viral tests and is performed by physicians in the Genetics department.

Sample Condition and Report Delivery

The H. Influenza RNA Detection Qualitative Test can be performed on various sample conditions, including C.S.F, bronchial swabs, bronchial lavage, and more. The report is typically delivered on the 3rd working day via email within 36 hours or on phone within 24 hours.

Pre Test Information

Prior to undergoing the H. Influenza RNA Detection Qualitative Test, patients are required to sign a consent document. It is also recommended to bring any clinical history of the patient related to H. Influenza for a more accurate diagnosis.

In conclusion, the H. Influenza RNA Detection Qualitative Test offered by DNA Labs UAE is a reliable and effective method for the detection of H. Influenzae infections. With its high sensitivity, specificity, and rapid turnaround time, this test aids in prompt diagnosis and appropriate treatment. If you are experiencing symptoms related to H. Influenzae, consult a physician and consider undergoing this test for accurate diagnosis and personalized treatment.

Test Name H. Influenza RNA Detection Qualitative Test
Components
Price 1160.0 AED
Sample Condition C.S.F, Bronchial Swabs, Bronchial lavage etc.
Report Delivery 3rd Working Day Email:-36 hours.On phone: 24 hours
Method Real Time PCR
Test type Viral
Doctor Physician
Test Department: Genetics
Pre Test Information Need to sign Consent document and bring any clinical history of patient forH. Influenza (RNA Detection) QualitativeTest
Test Details

The H. Influenza (RNA Detection) Qualitative Test is a diagnostic test used to detect the presence of RNA from the Haemophilus influenzae bacterium. This test is primarily used in clinical laboratories to identify the presence of H. Influenzae in patient samples, such as blood, cerebrospinal fluid, or respiratory secretions.

H. Influenzae is a gram-negative bacterium that can cause a variety of infections, including respiratory tract infections, meningitis, and bacteremia. Rapid and accurate detection of H. Influenzae is crucial for appropriate patient management and treatment decisions.

The qualitative test involves the use of a nucleic acid amplification technique, such as polymerase chain reaction (PCR) or loop-mediated isothermal amplification (LAMP), to amplify the RNA from H. Influenzae in the patient sample. The amplified RNA is then detected using specific molecular probes that bind to the target RNA sequence of H. Influenzae.

The test results are usually reported as either positive or negative for the presence of H. Influenzae RNA. A positive result indicates that the bacterium is present in the patient sample, while a negative result suggests its absence.

The H. Influenza (RNA Detection) Qualitative Test offers several advantages, including high sensitivity and specificity, rapid turnaround time, and the ability to detect low levels of H. Influenzae in the sample. It is a valuable tool for the diagnosis of H. Influenzae infections and helps guide appropriate treatment decisions.

It is important to note that this test specifically detects RNA from H. Influenzae and cannot differentiate between different strains or serotypes of the bacterium. Additional testing may be required to determine the specific strain or serotype present in the patient sample.

Overall, the H. Influenza (RNA Detection) Qualitative Test is a reliable and effective method for the detection of H. Influenzae infections, aiding in prompt diagnosis and appropriate treatment.